Celldex Therapeutics shares owned by Natixis
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Natixis
from 13F filings
Historical chart of Natixis investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Natixis
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $4.2M | 232k | 17.93 |
| 2024-12-31 | $399k | 16k | 25.27 |
| 2024-06-30 | $6.1M | 166k | 37.01 |
| 2024-03-31 | $9.0M | 214k | 41.97 |